First Light Asset Management, LLC
- SEC CIK
- 0001600004
- Latest filing
- Aug 14, 2026
Holdings in Q3 2023
Holdings as of Sep 30, 2023, filed Nov 14, 2023. Long positions only; changes compare share counts with Q2 2023.
- Positions
- 75
- −4 vs. Q2 2023
- Portfolio value
- $1.05B
- −$223.1M (−17.5%) vs. Q2 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| PRTAProthena Corp Public Ltd Co | SHS | 1,494,039 | $72.1M | 6.8% | −6,090−0.4% | Reduced | History |
| ATRCAtriCure, Inc. | COM | 1,489,407 | $65.2M | 6.2% | +27,772+1.9% | Added | History |
| SIBNSI-BONE, Inc. | COM | 2,524,093 | $53.6M | 5.1% | +409,264+19.4% | Added | History |
| KRTXKaruna Therapeutics, Inc. | COM | 303,137 | $51.3M | 4.9% | +94,391+45.2% | Added | History |
| PLRXPliant Therapeutics, Inc. | COM | 2,933,260 | $50.9M | 4.8% | +1,123,084+62.0% | Added | History |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 1,583,329 | $47.1M | 4.5% | +26,107+1.7% | Added | History |
| MODNModel N, Inc. | COM | 1,886,218 | $46.0M | 4.4% | +20,693+1.1% | Added | History |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 2,070,853 | $41.6M | 4.0% | +331,404+19.1% | Added | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 1,125,032 | $40.1M | 3.8% | +535,069+90.7% | Added | History |
| ATECAlphatec Holdings, Inc. | COM NEW | 3,033,541 | $39.3M | 3.7% | +61,664+2.1% | Added | History |
| NEONeogenomics Inc | COM NEW | 3,028,913 | $37.3M | 3.5% | +336,856+12.5% | Added | History |
| FNAParagon 28, Inc. | COM | 2,737,878 | $34.4M | 3.3% | +680,571+33.1% | Added | History |
| TMDXTransMedics Group, Inc. | COM | 618,100 | $33.8M | 3.2% | +240,636+63.8% | Added | History |
| TNDMTandem Diabetes Care Inc | COM NEW | 1,440,966 | $29.9M | 2.8% | +840,199+139.9% | Added | History |
| HCATHealth Catalyst, Inc. | COM | 2,930,144 | $29.7M | 2.8% | +389,185+15.3% | Added | History |
| TCMDTactile Systems Technology Inc | COM | 2,071,419 | $29.1M | 2.8% | +1,360,074+191.2% | Added | History |
| OFIXOrthofix Medical Inc. | COM | 1,852,438 | $23.8M | 2.3% | −606,691−24.7% | Reduced | History |
| PHLTPerformant Healthcare Inc | COM | 9,378,296 | $21.2M | 2.0% | +128,613+1.4% | Added | History |
| XENEXenon Pharmaceuticals Inc. | COM | 602,070 | $20.6M | 2.0% | +263,424+77.8% | Added | History |
| TELATELA Bio, Inc. | COM | 2,480,264 | $19.8M | 1.9% | +754,764+43.7% | Added | History |
| OPRXOptimizeRx Corp | COM NEW | 2,486,047 | $19.3M | 1.8% | +614,248+32.8% | Added | History |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 374,412 | $18.9M | 1.8% | +374,412 | New | History |
| AXNXAxonics, Inc. | COM | 321,173 | $18.0M | 1.7% | +8,387+2.7% | Added | History |
| STVNStevanato Group S.p.A. | ORD SHS | 584,755 | $17.4M | 1.7% | +470,479+411.7% | Added | History |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 848,477 | $17.0M | 1.6% | +90,642+12.0% | Added | History |
| INSMINSMED Inc | COM PAR $.01 | 643,588 | $16.3M | 1.5% | −2,098−0.3% | Reduced | History |
| KRMDKORU Medical Systems, Inc. | COM | 5,287,296 | $14.3M | 1.4% | −12,343−0.2% | Reduced | History |
| ANABAnaptysbio, Inc | COM | 790,806 | $14.2M | 1.3% | +468,598+145.4% | Added | History |
| OMCLOmnicell, Inc. | COM | 309,244 | $13.9M | 1.3% | −12,420−3.9% | Reduced | History |
| KROSKeros Therapeutics, Inc. | COM | 421,438 | $13.4M | 1.3% | +4,608+1.1% | Added | History |
| HALOHalozyme Therapeutics, Inc. | COM | 313,536 | $12.0M | 1.1% | −270,712−46.3% | Reduced | History |
| OMOutset Medical, Inc. | COM | 1,021,324 | $11.1M | 1.1% | +383,902+60.2% | Added | History |
| KIDSOrthopediatrics Corp | COM | 305,238 | $9.77M | 0.9% | +6,262+2.1% | Added | History |
| AXGNAxogen, Inc. | COM | 1,925,132 | $9.63M | 0.9% | −48,567−2.5% | Reduced | History |
| SCTLSocietal CDMO, Inc. | COM | 19,676,396 | $9.23M | 0.9% | +6,271,366+46.8% | Added | History |
| IRTCiRhythm Holdings, Inc. | COM | 88,039 | $8.30M | 0.8% | +88,039 | New | History |
| GHGuardant Health, Inc. | COM | 198,783 | $5.89M | 0.6% | +1,079+0.5% | Added | History |
| GMABGenmab A/S | SPONSORED ADS | 157,147 | $5.54M | 0.5% | −1,362−0.9% | Reduced | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 61,756 | $5.46M | 0.5% | +1,102+1.8% | Added | History |
| MXCTMaxcyte, Inc. | COM | 1,073,110 | $3.35M | 0.3% | −784,456−42.2% | Reduced | History |
| SONXSonendo, Inc. | COM | 4,185,619 | $3.12M | 0.3% | 00.0% | Unchanged | History |
| MIROMiromatrix Medical Inc. | COM | 2,278,670 | $2.99M | 0.3% | +52,930+2.4% | Added | History |
| TECHBIO-TECHNE Corp | COM | 32,889 | $2.24M | 0.2% | −289−0.9% | Reduced | History |
| OKUROnKure Therapeutics, Inc. | COM | 272,317 | $2.07M | 0.2% | +22,317+8.9% | Added | History |
| SLPSimulations Plus, Inc. | COM | 35,057 | $1.46M | 0.1% | −298−0.8% | Reduced | History |
| CUTRCutera Inc | COM | 240,078 | $1.45M | 0.1% | −330,651−57.9% | Reduced | History |
| HUMHumana Inc | Stock | 888 | $432.0K | <0.1% | 00.0% | Unchanged | History |
| NVSNovartis AG | ADR | 4,123 | $420.0K | <0.1% | 00.0% | Unchanged | History |
| FMSFresenius Medical Care AG | SPONSORED ADR | 19,490 | $419.8K | <0.1% | 00.0% | Unchanged | History |
| SNYSanofi | SPONSORED ADR | 7,711 | $413.6K | <0.1% | 00.0% | Unchanged | History |
| EXELExelixis, Inc. | COM | 18,445 | $403.0K | <0.1% | 00.0% | Unchanged | History |
| TAKTakeda Pharmaceutical Co Ltd | ADR | 25,630 | $396.5K | <0.1% | 00.0% | Unchanged | History |
| ELVElevance Health, Inc. | Stock | 886 | $385.8K | <0.1% | 00.0% | Unchanged | History |
| CNCCentene Corp | Stock | 5,521 | $380.3K | <0.1% | 00.0% | Unchanged | History |
| ENOVEnovis CORP | COM | 7,203 | $379.8K | <0.1% | 00.0% | Unchanged | History |
| ABBVAbbVie Inc. | Stock | 2,540 | $378.6K | <0.1% | +2,540 | New | History |
| SNNSmith & Nephew PLC | SPDN ADR NEW | 15,111 | $374.3K | <0.1% | 00.0% | Unchanged | History |
| GSKGSK plc | ADR | 10,058 | $364.6K | <0.1% | 00.0% | Unchanged | History |
| GILDGilead Sciences, Inc. | Stock | 4,526 | $339.2K | <0.1% | 00.0% | Unchanged | History |
| JNJJohnson & Johnson | Stock | 2,161 | $336.6K | <0.1% | 00.0% | Unchanged | History |
| MDTMedtronic plc | Stock | 4,188 | $328.2K | <0.1% | 00.0% | Unchanged | History |
| VTRSViatris Inc | Stock | 33,010 | $325.5K | <0.1% | 00.0% | Unchanged | History |
| QDELQuidelOrtho Corp | COM | 4,257 | $310.9K | <0.1% | 00.0% | Unchanged | History |
| AVTRAvantor, Inc. | COM | 14,596 | $307.7K | <0.1% | 00.0% | Unchanged | History |
| Bayer AG072730302 | Common Stock | 25,475 | $305.7K | <0.1% | 00.0% | Unchanged | – |
| UTHRUnited Therapeutics Corp | COM | 1,345 | $303.8K | <0.1% | 00.0% | Unchanged | History |
| HCAHCA Healthcare, Inc. | COM | 1,160 | $285.3K | <0.1% | 00.0% | Unchanged | History |
| BIIBBiogen Inc. | COM | 1,096 | $281.7K | <0.1% | 00.0% | Unchanged | History |
| XRAYDentsply Sirona Inc. | Stock | 8,228 | $281.1K | <0.1% | 00.0% | Unchanged | History |
| QGENQiagen N.V. | SHS NEW | 6,912 | $279.9K | <0.1% | 00.0% | Unchanged | History |
| IARTIntegra Lifesciences Holdings Corp | COM NEW | 7,261 | $277.3K | <0.1% | 00.0% | Unchanged | History |
| PDCOPatterson Companies, Inc. | COM | 9,264 | $274.6K | <0.1% | 00.0% | Unchanged | History |
| RVTYRevvity, Inc. | COM | 2,223 | $246.1K | <0.1% | 00.0% | Unchanged | History |
| LHLabcorp Holdings Inc. | COM NEW | 1,218 | $244.9K | <0.1% | 00.0% | Unchanged | History |
| OGNOrganon & Co. | Stock | 12,716 | $220.8K | <0.1% | 00.0% | Unchanged | History |
Sold out since Q2 2023 (7)
Positions held at the end of Q2 2023 that are gone from this filing.
| Security | Class | Shares in Q2 2023 | Value in Q2 2023 | % of portfolio in Q2 2023 | History |
|---|---|---|---|---|---|
| RETAReata Pharmaceuticals Inc | CL A | 1,432,208 | $146.0M | 11.4% | History |
| Abcam PLC000380204 | ADS | 710,745 | $17.4M | 1.4% | – |
| KRYSKrystal Biotech, Inc. | COM | 101,259 | $11.9M | 0.9% | History |
| PFEPfizer Inc | Stock | 140,235 | $5.14M | 0.4% | History |
| CSTLCastle Biosciences Inc | COM | 160,126 | $2.20M | 0.2% | History |
| AKUAkumin Inc. | COM | 1,575,098 | $283.5K | <0.1% | History |
| SYNHSyneos Health, Inc. | CL A | 5,736 | $241.7K | <0.1% | History |